Can Routine Eye Tests Predict Dementia Risk with AI?

Researchers are developing a groundbreaking digital tool that can predict dementia risk based on routine eye tests conducted by high street opticians. Led by the University of Edinburgh and Glasgow Caledonian University, the NeurEYE research team has amassed nearly a million eye scans from opticians across Scotland, forming the world’s largest dataset of its kind. Utilizing AI and machine learning, scientists analyze these images, correlating them with patient data that includes demographics, treatment history, and pre-existing conditions. This anonymized data helps identify patterns indicating one’s risk of developing dementia and provides an overall picture of brain health.

AI-Powered Diagnostic Tools

Eye as the Window to Brain Health

Baljean Dhillon, Professor of Clinical Ophthalmology at the University of Edinburgh and NeurEYE co-lead, notes that the eye’s blood vessels and neural pathways are intimately connected to the brain, making it an effective window for early dementia detection. Unlike complex brain scans, examining the retina is much simpler and can be performed with the equipment available at any UK high street optician. This innovative method leverages the advanced imaging capabilities used in routine eye exams to extract invaluable insights into the state of a person’s neurological health.

The use of optical coherence tomography (OCT), a non-invasive imaging technique, allows eye care professionals to capture detailed cross-sectional images of the retina. AI algorithms, trained on extensive datasets, can detect subtle changes in retinal structures that may indicate early signs of dementia. This approach not only democratizes access to potentially life-saving diagnostic tools but also simplifies the testing process, making it more accessible and less intimidating for patients. As a result, individuals may benefit from earlier interventions and better management of their condition, ultimately improving their quality of life.

Integration with Healthcare Systems

Optometrists could soon use this software as both a predictive and diagnostic tool for conditions such as Alzheimer’s. It could help them refer patients to secondary health services if initial signs of brain disease are detected and monitor cognitive decline. Ian Cameron, an optometrist from Edinburgh, emphasizes the unique position optometrists hold in consistently monitoring patients’ eye health, which with the help of AI, can extend to broader health insights. This integration within healthcare systems paves the way for a seamless flow of data and more coordinated care plans tailored to individual needs.

The ability to identify individuals at risk of dementia earlier can also accelerate the development of new treatments by improving patient selection for trials and enhancing treatment monitoring. Miguel Bernabeu, Professor of Computational Medicine at the Usher Institute and co-lead of NeurEYE, underscores the importance of training AI algorithms on diverse datasets to avoid bias and ensure equitable disease prediction. This collaborative effort among researchers, healthcare providers, and technology experts aims to bridge the gap between cutting-edge AI advancements and practical medical applications.

Privacy and Data Security

Safeguarding Patient Information

The data is securely stored in the Scottish National Safe Haven, thereby ensuring patients’ privacy while facilitating valuable research. Researchers work diligently to maintain stringent data protection protocols, ensuring that patient information remains confidential and anonymous. This rigorous approach to data security reassures patients that their personal information is protected while contributing to groundbreaking research efforts that have the potential to transform healthcare outcomes.

This initiative, supported by the Public Benefit and Privacy Panel for Health and Social Care under NHS Scotland, is part of a larger effort funded by NEURii. This global collaboration includes pharmaceutical company Eisai, Gates Ventures, LifeArc, and Health Data Research UK. The NeurEYE project follows SCAN-DAN, another NEURii-funded project that uses AI to predict dementia through brain scans. These initiatives highlight the importance of international partnerships in tackling some of the most pressing health challenges of our time.

Future Implications and Next Steps

The ultimate goal is to integrate this tool into regular optometric practices, providing an early warning system for dementia and related cognitive disorders. This breakthrough has the potential to revolutionize brain health monitoring and pave the way for early intervention strategies.

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later